Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.

Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Abstract Text:

    hubert Hubert ,andre igneeAndre Ignee,gudrun schuesslerGudrun Schuessler,michaela ottMichaela Ott,christoph f dietrichChristoph F Dietrich,

    BACKGROUND: Imaging of liver tumours might be improved by contrast-enhanced ultrasonography, which allows much better demonstration of the microvascular system. The aim of this study was to assess the sonographic morphology and vascularity of neuroendocrine liver metastases. METHODS: Forty-eight patients with histologically proven neuroendocrine tumours (NET) and suspected liver metastases--as well as 50 consecutive patients with liver metastases of other origins--were included in a prospective study to evaluate tumour characteristics using B-mode, colour Doppler (CDI) and contrast-enhanced ultrasound (CEUS). RESULTS: In 4/48 patients with NET, liver biopsy revealed hemangiomas. The typical B-mode appearance was that of both echo-rich and echo-poor combined, also inhomogeneous depending on the size, and often centrally cystic. With CDI, neuroendocrine metastases appeared hypervascular (66%) or isovascular (34%). Metastases of another origin were hypovascular in 82%. With CEUS, neuroendocrine metastases showed increased arterial enhancement in 38 patients and hypoechoic appearance in the portalvenous phase in 39 patients. In liver metastases of another origin, the sensitivity for malignancy due to a hypoechoic appearance during the portalvenous phase was 100%. In liver metastases of NET origin the sensitivity for malignancy was 39/48 (82%). CONCLUSIONS: Neuroendocrine tumour metastases might show characteristics which are similar to hemangiomas. In patients with liver cirrhosis and severe fatty liver disease the identification of NET with CEUS as a malignant lesion is more difficult. The sensitivity of CEUS in identifying malignancy based on the lack of portalvenous enhancement is higher for metastases of other origin.

    Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Publishing Authors By Initials

    h H ,a igneeA Ignee,g schuesslerG Schuessler,m ottM Ott,cf dietrichCF Dietrich,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Scandinavian journal of gastroenterology

    VOLUME: 42

    Page Numbers: 652-62

    Journal Abbreviation:

    ISSN: 0036-5521

    DAY: 24

    MONTH: May

    YEAR: 2007

    Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 60105

    Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.

    AFFILIATION: Department of Gastroenterology and Internal Medicine, Hospital of Nagold, Germany.

    Country: Norway

    Norway Research PublicationNorway Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Scand J Gastroenterol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News